SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-127597
Filing Date
2018-04-24
Accepted
2018-04-24 06:16:03
Documents
6
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d550701d10ka.htm 10-K/A 65870
2 EX-10.40 d550701dex1040.htm EX-10.40 385552
3 EX-31.3 d550701dex313.htm EX-31.3 2829
4 EX-31.4 d550701dex314.htm EX-31.4 2868
5 GRAPHIC g550701g0420111216653.jpg GRAPHIC 4808
6 GRAPHIC g550701st_872.jpg GRAPHIC 7274
  Complete submission text file 0001193125-18-127597.txt   475221
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30171 | Film No.: 18770017
SIC: 2836 Biological Products, (No Diagnostic Substances)